OptimizeRx Corp. priced its public offering of 1,538,500 common shares at $13 each.
The Rochester, Mich.-based digital health messaging company also granted the underwriters a 30-day option to buy up to an additional 230,775 common shares at the same price.
Gross proceeds from the offering are expected to be about $20 million. Net proceeds will be used for general corporate purposes, which may include acquisitions.
William Blair & Co. LLC is acting as sole book-running manager for the offering, while B. Riley FBR is acting as lead manager. Roth Capital Partners and Lake Street Capital Markets LLC are acting as financial advisers for the offer.